Related Experiment Video
Updated: May 30, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
PP13, maternal ABO blood groups and the risk assessment of pregnancy complications
Nandor Gabor Than1, Roberto Romero, Hamutal Meiri
1First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary. nthan@med.wayne.edu
Insights
Maternal blood type influences levels of Placental Protein 13 (PP13), an early preeclampsia biomarker. Adjusting PP13 measurements for blood group enhances prediction accuracy for preeclampsia and intrauterine growth restriction (IUGR).
Area of Science:
- Biochemistry
- Immunology
- Genetics
Background:
- Placental Protein 13 (PP13) is an early biomarker for preeclampsia.
- PP13 is a placenta-specific galectin that binds beta-galactosides, components of ABO blood group antigens.
- This binding may affect PP13 bioavailability in maternal blood.
Purpose of the Study:
- To investigate PP13 binding to erythrocytes.
- To examine the effect of maternal blood group on serum PP13 levels.
- To assess PP13's performance in predicting preeclampsia and intrauterine growth restriction (IUGR).
Main Methods:
- Analysis of maternal serum PP13 datasets (n=1078 Caucasian, n=242 Hispanic) by blood group.
- In vivo, in vitro, and in silico studies of PP13 binding to ABO antigens and erythrocytes.
- Utilized PP13-immunostainings, flow-cytometry, and molecular modeling.
Main Results:
- Women with blood group AB had the lowest first-trimester serum PP13; blood group B had the highest throughout pregnancy.
- PP13 binding was strongest to AB erythrocytes and weakest to B erythrocytes.
- Adjusting PP13 multiples of median (MoMs) for maternal ABO blood group improved prediction accuracy for preeclampsia and IUGR.
Conclusions:
- Maternal ABO blood group influences PP13 bioavailability.
- ABO blood group may be a determinant for other lectins' bioavailability.
- Adjusting PP13 MoMs for ABO blood group enhances predictive accuracy for preeclampsia and IUGR.
Background:
Placental Protein 13 (PP13), an early biomarker of preeclampsia, is a placenta-specific galectin that binds beta-galactosides, building-blocks of ABO blood-group antigens, possibly affecting its bioavailability in blood.
Methods And Findings:
We studied PP13-binding to erythrocytes, maternal blood-group effect on serum PP13 and its performance as a predictor of preeclampsia and intrauterine growth restriction (IUGR). Datasets of maternal serum PP13 in Caucasian (n = 1078) and Hispanic (n = 242) women were analyzed according to blood groups. In vivo, in vitro and in silico PP13-binding to ABO blood-group antigens and erythrocytes were studied by PP13-immunostainings of placental tissue-microarrays, flow-cytometry of erythrocyte-bound PP13, and model-building of PP13--blood-group H antigen complex, respectively. Women with blood group AB had the lowest serum PP13 in the first trimester, while those with blood group B had the highest PP13 throughout pregnancy. In accordance, PP13-binding was the strongest to blood-group AB erythrocytes and weakest to blood-group B erythrocytes. PP13-staining of maternal and fetal erythrocytes was revealed, and a plausible molecular model of PP13 complexed with blood-group H antigen was built. Adjustment of PP13 MoMs to maternal ABO blood group improved the prediction accuracy of first trimester maternal serum PP13 MoMs for preeclampsia and IUGR.
Conclusions:
ABO blood group can alter PP13-bioavailability in blood, and it may also be a key determinant for other lectins' bioavailability in the circulation. The adjustment of PP13 MoMs to ABO blood group improves the predictive accuracy of this test.
Related Concept Videos
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Rh Blood Group
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...